Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It was developed by Eisai Co. and is marketed by Janssen-Cilag as rabeprazole sodium under the brand names AcipHex (pronounced "acifex", referring to pH) in the US, Pariet in Japan and Canada, & Rablet in India.
| Property | Value |
| dbpedia-owl:Drug/atcPrefix
| |
| dbpedia-owl:Drug/atcSuffix
| |
| dbpedia-owl:Drug/casNumber
| |
| dbpedia-owl:Drug/drugbank
| |
| dbpedia-owl:Drug/iupacName
|
- 2-([4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl)-1H-benzo[d]imidazole
|
| dbpedia-owl:Drug/pubchem
| |
| dbpedia-owl:atcPrefix
| |
| dbpedia-owl:atcSuffix
| |
| dbpedia-owl:casNumber
| |
| dbpedia-owl:drugbank
| |
| dbpedia-owl:iupacName
|
- 2-([4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl)-1H-benzo[d]imidazole
|
| dbpedia-owl:pubchem
| |
| dbpedia-owl:thumbnail
| |
| dbpprop:abstract
|
- Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It was developed by Eisai Co. and is marketed by Janssen-Cilag as rabeprazole sodium under the brand names AcipHex (pronounced "acifex", referring to pH) in the US, Pariet in Japan and Canada, & Rablet in India.
- El rabeprazol es un medicamento inhibidor de la bomba de protones en el estómago usado en el tratamiento a corto plazo de las erosiones y úlceras causadas por enfermedades de reflujo gastroesofágico. También se indica para el tratamiento de enfermedades en la que el organismo produce un exceso de ácido gástrico, como en el síndrome de Zollinger-Ellison. Puede indicarse en la triple terapia que se administra para la erradicación del Helicobacter pylori.
- Il rabeprazolo sodico è un farmaco inibitore della pompa protonica. Viene prodotto dalla casa farmaceutica Janssen-Cilag, e commercializzato in Italia con il brand Pariet®.
- Rabeprazol (rabeprazole) – organiczny związek chemiczny, lek z grupy inhibitorów pompy protonowej, zmniejszający wydzielanie do światła żołądka jonów wodorowych. Jest stosowany głównie w terapii choroby wrzodowej.
- Rabeprazol é um fármaco antiulceroso da classe dos inibidores da bomba de protões (IBP). Foi desenvolvido pela Eisai Co. e é comercializado pela Janssen-Cilag como rabeprazol sódio sob as marcas Aciphex® e Pariet®. Omeprazol Lansoprazol Pantoprazol
- Рабепрозол — противоязвенный препарат из группы ингибиторов протонной помпы. Разработан en:Eisai Co. , реализуется Janssen-Cilag в виде натриевой соли (rabeprazole sodium) под бренд-неймами Aciphex или Париет.
- Rabeprazol, proton pompası inhibitörleri grubundan bir antiülser ilaçtır. Ticari adlarının bazıları ABD'de üretilen Aciphex, Johnson&Johnson tarafından üretilen Pariet ve Sandoz tarafından üretilen Prabex'tir. 20 Mg Tablet formu için
|
| dbpprop:atcPrefix
| |
| dbpprop:atcSuffix
| |
| dbpprop:bioavailability
| |
| dbpprop:c
| |
| dbpprop:casNumber
| |
| dbpprop:chemspiderid
| |
| dbpprop:drugbank
| |
| dbpprop:eliminationHalfLife
| |
| dbpprop:excretion
| |
| dbpprop:h
| |
| dbpprop:hasPhotoCollection
| |
| dbpprop:image
| |
| dbpprop:iupacName
|
- 2-([4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl)-1H-benzo[d]imidazole
|
| dbpprop:legalUk
| |
| dbpprop:legalUs
| |
| dbpprop:licenceUs
| |
| dbpprop:metabolism
| |
| dbpprop:molecularWeight
| |
| dbpprop:n
| |
| dbpprop:o
| |
| dbpprop:pregnancyUs
| |
| dbpprop:pubchem
| |
| dbpprop:reference
| |
| dbpprop:routesOfAdministration
| |
| dbpprop:s
| |
| dbpprop:smiles
|
- COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C
|
| dbpprop:verifiedrevid
| |
| dbpprop:width
| |
| dbpprop:wikiPageUsesTemplate
| |
| rdf:type
| |
| rdfs:comment
|
- Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It was developed by Eisai Co. and is marketed by Janssen-Cilag as rabeprazole sodium under the brand names AcipHex (pronounced "acifex", referring to pH) in the US, Pariet in Japan and Canada, & Rablet in India.
- El rabeprazol es un medicamento inhibidor de la bomba de protones en el estómago usado en el tratamiento a corto plazo de las erosiones y úlceras causadas por enfermedades de reflujo gastroesofágico. También se indica para el tratamiento de enfermedades en la que el organismo produce un exceso de ácido gástrico, como en el síndrome de Zollinger-Ellison. Puede indicarse en la triple terapia que se administra para la erradicación del Helicobacter pylori.
- Il rabeprazolo sodico è un farmaco inibitore della pompa protonica. Viene prodotto dalla casa farmaceutica Janssen-Cilag, e commercializzato in Italia con il brand Pariet®.
- Rabeprazol (rabeprazole) – organiczny związek chemiczny, lek z grupy inhibitorów pompy protonowej, zmniejszający wydzielanie do światła żołądka jonów wodorowych. Jest stosowany głównie w terapii choroby wrzodowej.
- Rabeprazol é um fármaco antiulceroso da classe dos inibidores da bomba de protões (IBP). Foi desenvolvido pela Eisai Co. e é comercializado pela Janssen-Cilag como rabeprazol sódio sob as marcas Aciphex® e Pariet®. Omeprazol Lansoprazol Pantoprazol
- Рабепрозол — противоязвенный препарат из группы ингибиторов протонной помпы. Разработан en:Eisai Co. , реализуется Janssen-Cilag в виде натриевой соли (rabeprazole sodium) под бренд-неймами Aciphex или Париет.
- Rabeprazol, proton pompası inhibitörleri grubundan bir antiülser ilaçtır. Ticari adlarının bazıları ABD'de üretilen Aciphex, Johnson&Johnson tarafından üretilen Pariet ve Sandoz tarafından üretilen Prabex'tir. 20 Mg Tablet formu için
|
| rdfs:label
|
- Rabeprazole
- Rabeprazol
- Rabeprazolo sodico
- Rabeprazol
- Rabeprazol
- Рабепразол
- Rabeprazol
|
| owl:sameAs
| |
| skos:subject
| |
| foaf:depiction
| |
| foaf:homepage
| |
| foaf:page
| |
| is dbpprop:redirect
of | |
| is owl:sameAs
of | |